Global Surgical Ablation Market Size to Reach USD 11.91 Billion in 2032 | Emergen Research

Increasing prevalence of chronic diseases is a key factor driving market revenue growth

Vancouver, Sept. 13, 2023 (GLOBE NEWSWIRE) — The global surgical ablation market size was USD 6.14 Billion in 2022 and is expected to register a steady revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of chronic disorders is a key factor driving market revenue growth. Surgical ablation is a type of procedure to remove or reprogram tissue in the body that is damaged or causing interference. 

According to the International Diabetes Federation’s Diabetes Atlas, for 2021, around 537 million adults worldwide were diagnosed with diabetes in 2021, with the figure expected to rise to 643 million by 2030. Diabetes and strokes are common symptoms associated with cardiovascular disorders. Catheter ablation of Atrial Fibrillation (AF) appears to be a safe therapy that significantly reduces symptom load in people with Diabetic Mellitus (DM).

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2287

However, high cost of investments in such treatments is a key factor, which could restrain market revenue growth. Surgical ablation procedure often requires specialized equipment and technology, including advanced imaging systems, and energy delivery devices. The initial investment, maintenance, and upgrades of this equipment can contribute significantly to the overall cost of procedure.

Scope of Research

Report Details Outcome
Market Size in 2022 USD 6.14 Billion
CAGR (2023–2032) 6.8%
Revenue Forecast To 2032 USD 11.91 Billion
Base Year For Estimation 2022
Historical Data 2019–2021
Forecast Period 2023–2032
Quantitative Units Revenue in USD Billion and CAGR in % from 2023 to 2032
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered Technology, application, end-use, and region
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country Scope U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies Profiled AngioDynamics, Inc., Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, AtriCure, Inc., Olympus Corporation, Smith & Nephew plc, Minerva Surgical, Inc., Merit Medical Systems, Inc., and Biotronik SE & Co KG
Customization Scope 10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2287

Major Companies and Competitive Landscape

The global surgical ablation market is fragmented, with several medium and large-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing new ablation devices. Some major players included in the global surgical ablation market report are:

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic plc
  • AtriCure, Inc.
  • Olympus Corporation
  • Smith & Nephew plc
  • Minerva Surgical, Inc.
  • Merit Medical Systems, Inc.
  • Biotronik SE & Co. KG

Strategic Development

  • In October 2022, PENTAX Medical, a pioneer in diagnostic and therapeutic endoscopy solutions in the healthcare sector introduced Canadian introduction of C2 CryoBalloon Ablation System for the treatment of Barrett’s Oesophagus. In comparison to current RFA systems, theC2 CryoBalloon Ablation System offers hospitals considerable economic benefit with a low capital investment.
  • In March 2022, Quantum Surgical, an innovative medical robotics business, has received 510(k) clearance from the US Food and Drug Administration (FDA) for Epione, a new category of interventional oncology robotics focused to minimally invasive liver cancer treatment. Percutaneous tumor ablation is a proven but underutilized therapy, and Epione will enable for the expansion of this less invasive treatment to more people with liver cancer.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2287

Some Key Highlights From the Report

  • The Radiofrequency (RF) ablation segment accounted for largest revenue share in the global surgical ablation market in 2022. This is because RF ablation generates heat that is used to kill tissue by using radio waves. The complete treatment typically takes between 30 and 90 minutes and it is recommended that the patient be driven home after the procedure. RF ablation is used to relieve persistent pain caused by arthritis or other joint problems. This surgery, which is a mainstay of back pain treatment, targets the nerves that send pain signals from joints. It can provide long-term comfort by interrupting communication between nerves and pain processing center in the brain. In addition, RF ablation is performed under fluoroscopic (x-ray) supervision and should not be performed on patients who are infected, pregnant, or have bleeding issues.
  • The oncology segment is expected to register steadily fast revenue growth rate in the global surgical ablation market during the forecast period. This is owing to the prevalence of cancer such as prostate and breast. Ablation is a procedure that eliminates tumors in the liver without removing them. These methods can be utilized on people who have a few tiny tumors. RF ablation is most usually used to treat a cancerous location that is producing difficulties, such as pain or other discomfort, and it is not typically utilized as the primary treatment for most cancers.
  • The North America market is expected to account for largest revenue share in the global surgical ablation market over the forecast period. This is due to increasing prevalence of chronic disorders and presence of better and advanced healthcare infrastructure. Moreover, technological advancements in ablation devices in this region is also expected to drive market revenue growth over the forecast period.
  • In February 2023, Hologic Inc., an internationally renowned company specializing in women’s health, revealed that the NovaSure V5 worldwide endometrial ablation (GEA) apparatus has received authorization for use in Canada and Europe. This advanced iteration introduces improved attributes aimed at addressing a diverse array of cervical and uterine structures. These developments further augment the already impressive reputation of NovaSure, which has positively impacted the lives of three million patients globally.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@  https://www.emergenresearch.com/industry-report/surgical-ablation-market

Emergen Research has segmented the global surgical ablation market on the basis of technology application, end-use, and region:

  • Technology Outlook (Revenue, USD Billion; 2019-2032)
    • Radiofrequency Ablation
    • Light/Laser Ablation
    • Electrical Ablation
    • Cryoablation
    • Microwave Ablation
    • Ultrasound Ablation
    • Hydromechanical Ablation
  • Application Outlook (Revenue, USD Billion; 2019-2032)
    • Oncology
    • Cardiovascular
    • Orthopedic
    • Gastrointestinal
    • Soft Tissue
    • Others
  • End-use Outlook (Revenue, USD Billion; 2019-2032)
    • Hospitals
    • Ambulatory Surgical Centers
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
        • U.S.
        • Canada
        • Mexico
    • Europe
        • Germany
        • France
        • UK
        • Italy
        • Spain
        • Benelux
        • Rest of Europe
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of APAC
    • Latin America
        • Brazil
        • Rest of LATAM
    • Middle East & Africa
        • Saudi Arabia
        • UAE
        • South Africa
        • Turkey
        • Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Pediatric Psoriasis Market Analysis By Type (Plaque, Guttate, Pustular, Inverse, Erythrodermic, Mucosal/oral, Nail, Napkin or diaper, Photosensitive, Flexural), By Treatment (Topical therapy, Oral, Injections), By End Use (Hospitals, Specialty Clinics, Ambulatory Care Centers, Research Organizations), By Region, Forecasts to 2027

Pulse Oximeter Market, By Product Type (Handheld Devices, Fingertip, Tabletop, Wearable), By Technology (Smart and Conventional), By End-Use (Hospitals and Healthcare & Diagnostic Centers), and By Region Forecast to 2030

Transcatheter Mitral Valve Implantation Market Analysis, By Product (Mechanical Valves & Bioprosthetic Tissue (Biological) Valves), By Application (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation), By End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), Forecasts to 2027

mHealth Market, By Platform (Mobile Apps and Wearable Devices), By Application (Remote Monitoring and Disease and Epidemic Outbreak Tracking), By End-Use (Healthcare Providers and Hospitals and Clinics), and By Region Forecast to 2030

Advanced Wound Care Market By Product Type (Moist Wound Dressing, Wound Therapy Devices), By Wound Type (Surgical Wounds, Ulcers, Burns, Traumatic Wounds), By End-User (Hospitals and Clinics, Home Care Settings), and By Region, Forecasts to 2027

Alternative Proteins Market, By Source (Plant-based, Insect-based, Microbial-based) By Application (Meat Substitutes, Dairy Alternatives, Bakery, Nutrient Supplement), By Form (Dry Form, Wet Form), and By Region Forecast to 2030

Biologics Market, By Source (Microbial and Mammalian), By Product Type (Monoclonal Antibodies, Vaccines, Cellular-Based Biologics, and Gene-Based Biologics), By Application, and By Region Forecast to 2030

Blockchain in Healthcare Market By Type (Permissioned/Private Blockchain, Permissionless/Public Blockchain), By Application, By End-Users (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-surgical-ablation-market

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy